List of companies in Vida Ventures's investment portfolio
Name | Description | Industry | Official Website | Location | ||
|---|---|---|---|---|---|---|
Allogene Therapeutics is a San Francisco, California-based biotechnology company specializing in the development of allogeneic CAR T("AlloCAR TTM") therapies for cancer. | ||||||
Ophthalmology Indications | ||||||
Kronos Bio is a Cambridge, Massachusetts-based therapeutics company working on research and development of therapies that modulate historically recalcitrant cancer targets. | ||||||
A genetic medicines company in Massachusetts that focuses on patients suffering from rare genetic diseases. | ||||||
Small Molecules | ||||||
Kyverna is a cell therapy company engineering a new class of curative living medicines for inflammatory and autoimmune diseases. | ||||||
A2 Biotherapeutics, Inc. is a biotechnology research company developing T-cell therapies designed to attack solid tumors while sparing normal cells | ||||||
PACT Pharma is synthesizing neo-epitope targeted T cells and producing a personalized adoptive cell therapy designed to benefit each cancer patient. | ||||||
Asklepios Biopharmaceutical is a company in North Carolina. | ||||||
Pionyr Immunotherapeutics is a San Francisco-based biotechnology company and developer of cancer immunotherapies designed to target the tumor microenvironment. | ||||||
California Institute for Quantitative Biosciences is a California-based biotechnology company founded in 2000. It is a partnership between Venture Capital, California State, Private Industry, University of California Campuses Berkeley, San Francisco and Santa Cruz. | ||||||
ReCode Therapeutics is a genetic medicines company that specializes in mRNA and gene correction therapeutics. | ||||||
Locanabio is a San Diego, California-based biotechnology company developing RNA-targeting gene therapies. | ||||||
Aktis Oncology is a biotechnology company discovering and developing a novel class of targeted radiopharmaceuticals. | ||||||
Neogene Therapeutics, Inc. is a t Cell Therapies for Cancer founded in 2018. | ||||||
Vigil Neurosciences is a microglia-based Therapeutics for Neurodegenerative Diseases. | ||||||
InnoSkel is a therapies for Rare Skeletal Diseases founded in 2020 by Elvire Gouze. | ||||||
Halda is inventing novel precision medicines for oncology. Specifically, we are developing RIPTAC™ therapeutics, a new drug modality for the treatment of cancer. Founded by world renowned Yale scientist, Professor Craig Crews, Halda invented RIPTAC therapeutics as an innovative cancer treatment approach that does not rely on traditional oncogenic | ||||||
Protego Biopharma is a Therapeutic and Diagnostic company that brings medicines to patients. | ||||||
IconOVir Bio is an oncolytic Virus Therapy. | ||||||
Affini-T Therapeutics, Inc is a TCR Cell Therapy. | ||||||
Volastra Therapeutics is a therapies for the treatment of metastatic cancers. | ||||||
Alterome Therapeutics, Inc. is an oncology Treatments founded in 2021 by Eric Murphy. | ||||||
Quanta Therapeutics, Inc. is a company founded in 2018. | ||||||
Tectonic Therapeutic, Inc. is a Watertown, Massachusetts-based biotechnology company. |
